| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9243 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.7040 |
| P-glycoprotein Substrate | Non-substrate | 0.6777 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6670 |
| Non-inhibitor | 0.8706 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7870 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4824 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8274 |
| CYP450 2D6 Substrate | Non-substrate | 0.8374 |
| CYP450 3A4 Substrate | Non-substrate | 0.6492 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9324 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.5637 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7396 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.6572 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.5697 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8765 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9401 |
| Non-inhibitor | 0.8966 |
| AMES Toxicity | AMES toxic | 0.7171 |
| Carcinogens | Carcinogens | 0.6499 |
| Fish Toxicity | High FHMT | 0.9867 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9630 |
| Honey Bee Toxicity | Low HBT | 0.7616 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | II | 0.7407 |
| Carcinogenicity (Three-class) | Danger | 0.3514 |